The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Metastasis-directed radiotherapy in oligometastatic bladder and upper tract cancer: A single institution retrospective experience.
 
Patrick Carriere
No Relationships to Disclose
 
Omar Alhalabi
Consulting or Advisory Role - Adaptimmune; Bicycle Therapeutics; Cardinal Health; Seagen; Silverback Therapeutics
Research Funding - Arcus Biosciences (Inst); AstraZeneca (Inst); Genentech (Inst); Ikena Oncology (Inst)
 
Jianjun Gao
Consulting or Advisory Role - AstraZeneca; AstraZeneca; crispr therapeutics; Infinity Pharmaceuticals; Janssen; Pfizer; Seagen
Travel, Accommodations, Expenses - AstraZeneca
 
Amishi Shah
Consulting or Advisory Role - Bristol Myers Squibb Foundation; Exelixis; Pfizer/EMD Serono
Research Funding - 4D Pharma (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); EMD Serono (Inst)
 
Matthew Campbell
Honoraria - Axdev; Curio Science; Eisai; Exelixis; MJH Life Sciences; Seagen; Targeted Oncology
Consulting or Advisory Role - Exelixis
Research Funding - Apricity Health (Inst); Aravive (Inst); Exelixis (Inst); Janssen Oncology (Inst); Pfizer/EMD Serono (Inst); SeaGen (Inst)
Travel, Accommodations, Expenses - AVEO; Exelixis; SeaGen
 
Lauren Mayo
No Relationships to Disclose
 
Osama Mohamad
Employment - MD Anderson Cancer Center
 
Karen Hoffman
Employment - MD Anderson Cancer Center
Research Funding - Janssen (Inst); Varian Medical Systems (Inst)
 
Henry Mok
No Relationships to Disclose
 
Charmaigne Lozano
No Relationships to Disclose
 
Shalin Shah
No Relationships to Disclose
 
Ryan Park
No Relationships to Disclose
 
Sean Mcguire
No Relationships to Disclose
 
Ashish Kamat
Consulting or Advisory Role - Arquer Diagnostics; Asieris Pharmaceuticals; Aspira Women's Health (I); Astellas Pharma; AstraZeneca; CG Oncology; Cystotech; enGene; Ferring; Genentech; GlaxoSmithKline (I); ImmunityBio; Imvax; Janssen; Merck; Nonagen Bioscience; Pfizer; Seagen; Theralase; Valar Labs; Vivet Therapeutics
Research Funding - Arquer Diagnostics (Inst); enGene (Inst); FKD Therapies (Inst); Patient-Centered Outcomes Research Institute (PCORI) (Inst); Photocure (Inst); Seagen (Inst); SWOG (Inst)
Patents, Royalties, Other Intellectual Property - Patent: CyPRIT (Cytokine Predictors of Response to Intravesical Therapy) joint with UT MD Anderson Cancer Center
Other Relationship - Bladder Cancer Advocacy Network; European Urology Oncology; International Bladder Cancer Group (IBCG); Journal of Urology; UroToday
 
Neema Navai
No Relationships to Disclose
 
Kelly Bree
No Relationships to Disclose
 
Charles Guo
No Relationships to Disclose
 
Chad Tang
Employment - MD Anderson Cancer Center
Consulting or Advisory Role - Boston Scientific; Elekta; Lantheus Medical Imaging; MOLLI Surgical; Siemens Healthineers; Telix Pharmaceuticals
Research Funding - Myriad Genetics (Inst); Noxopharm (Inst)
Patents, Royalties, Other Intellectual Property - I have a patent on the utilization of a monoclonal antibody and we license this for use. We receive royalties <$1000 per year on this license.
Travel, Accommodations, Expenses - Vision RT
Other Relationship - Osler Institute; Wolters Kluwer
 
Seungtaek Choi
No Relationships to Disclose
 
Comron Hassanzadeh
No Relationships to Disclose